Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Deoxyuridine Monophosphate SCHEMBL8200 | 1.00 | DUT (0.77) | DUTTYMS | |
| Deoxyuridine Monophosphate SCHEMBL888328 | 1.00 | DUT (0.77) | DUTTYMS | |
| Deoxyuridine Monophosphate SCHEMBL25024676 | 1.00 | DUT (0.77) | DUTTYMS | |
| Deoxyuridine Monophosphate SCHEMBL9830961 | 0.96 | DUT (0.72) | DUTTYMS | |
| SCHEMBL4263613 | 0.92 | DUT (0.73) | DUTTYMS | |
| SCHEMBL5565558 | 0.92 | DUT (0.73) | DUTTYMS | |
| SCHEMBL5051998 | 0.92 | DUT (0.76) | DUTTYMS | |
| Deoxyuridine Monophosphate SCHEMBL5162672 | 0.92 | P2RY2 (0.71) | DUT | |
| SCHEMBL22198883 | 0.91 | DUT (0.75) | DUT | |
| SCHEMBL21067966 | 0.91 | DUT (0.78) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200114012-A1 | METHOD FOR PRODUCING A LIQUID COMPOSITION | UNIV LIVERPOOL (GB) | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200114012-A1 | METHOD FOR PRODUCING A LIQUID COMPOSITION | LIPA, LIPC, CEL | DUT 2776/4885TYMS 4230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.